- US11801300utility2023Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies0 cites
- US11802152utility2023Methods of Treating Fgf21-associated Disorders0 cites
- US11786498utility2023Sacubitril Calcium Salts0 cites
- US11787785utility2023Pyrazolopyridine Derivatives and Uses Thereof0 cites
- US11779649utility2023Antibodies to PMEL17 and Conjugates Thereof0 cites
- US11780927utility2023Anti-cd40 Antibodies for Use in Prevention of Graft Rejection0 cites
- US11767370utility2023Process for Concentration of Antibodies and Therapeutic Products Thereof0 cites
- US11759436utility2023Dosage Regimen of an S1P Receptor Modulator0 cites
- US11760735utility2023Compounds and Compositions for Treating Conditions Associated with NLRP Activity0 cites
- US11752162utility2023Compounds and Compositions for Treating Solid Tumors by Intratumoral Administration0 cites
- US11752211utility2023Fatty Acids and Their Use in Conjugation to Biomolecules0 cites
- US11753416utility2023Compounds and Compositions for Inducing Chondrogenesis0 cites
- US11747319utility2023Computer Method and System for Deriving Cell-to-cell Spatial Proximities0 cites
- US11738028utility2023Therapeutic Regimen0 cites
- US11723901utility2023Uses of Piperidinyl-indole Derivatives0 cites
- US11724992utility2023Compounds and Compositions for Treating Conditions Associated with NLRP Activity0 cites
- US11725246utility2023Methods of Treating Ophthalmic Disorders0 cites
- US11726092utility2023Method of Scoring a Sample Comprising Tumor Tissue0 cites
- US11718631utility2023Sulphonamides and Compositions Thereof for Treating Conditions Associated with NLRP Activity0 cites
- US11708366utility2023Heteroaryl Substituted Spiropiperidinyl Derivatives and Pharmaceutical Uses Thereof0 cites